Navigation Links
Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo

ATLANTA, July 28, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at the American Association for Clinical Chemistry (AACC) 2015 Clinical Lab Expo today by introducing several next-generation diagnostic testing platforms and a unique educational initiative that demonstrates how Roche is partnering with customers to redefine the value of the laboratory.

The new LabLeaders initiative ( was created to empower laboratories and the people within them through insight from industry innovators.  The website hosts original, exclusive content developed by progressive thought leaders who work as CEOs, physicians, lab directors, informatics experts, financial officers and strategic advisors. nationwide events deliver the content and workshops live, allowing participants to gain access to industry experts and their peers to share best practices.  

"Our lab customers tell us that they're looking for resources to help them maximize the value they deliver to clinicians, patients and other stakeholders," said Jack Phillips, president and CEO of Roche Diagnostics Corporation. "We're highlighting the LabLeaders initiative and several new diagnostics platforms at this year's Clinical Lab Expo to demonstrate how we can work together to achieve our shared goals."

In its booth (#1907), Roche is exhibiting a variety of in vitro diagnostics solutions designed to enhance testing efficiency and provide reliable clinical information in central labs and various point-of-care settings. Specific product areas include clinical chemistry and immunoassay testing, molecular diagnostics, lab automation, H&E staining, point-of-care testing, and information technology. The booth also includes a "Futures" area that offers a glimpse into pipeline diagnostics products that have not been submitted for FDA approval and are not yet available for sale in the U.S.

The Roche booth is also home to the Theater, where Expo attendees can hear brief updates throughout the day from experts about significant industry topics ranging from clinical decision making in the ED and increasing patient satisfaction to lab standardization, automation, lab intelligence and sustaining LEAN operations.

In addition, Roche is continuing its commitment to discussing critical industry issues by sponsoring five workshops in conjunction with the AACC 2015 annual meeting:

  1. Continuing the Conversation: Consulting in a Clinical Setting
  2. Clinical Decision Making in the ED During Influenza Season; Can Test Results Influence Practice and the Role of the cobas® Liat Influenza A/B Assay?
  3. Transitioning Your Institution to Next Gen Troponin T
  4. NT-proBNP in Latest Heart Failure Treatment
  5. Improving Patient Care with Molecular Testing: Current and Future Impacts

An overview of the booth, as well as a schedule of the Theater presentations and times and locations of Roche-sponsored events, can be found at

New products featured in the Roche booth this year include:

  • VENTANA HE 600 system*—a fully automated H&E staining solution with individual slide staining technology to virtually eliminate the risk of tissue cross contamination. The system is designed with lean methodology with minimum touch points and an intuitive operating system to help improve workflow.
  • cobas® 6800 system**—a fully automated solution for donor screening and clinical molecular testing, designed to deliver fully integrated automation and throughput with shorter time to results, providing greater flexibility to increase workflow efficiencies.
  • cobas® Liat System—a compact, innovative real-time PCR platform designed for on-demand STAT testing with results in 20 minutes or less, enabling confidence in rapid patient management at the point of care or in the laboratory.
  • CoaguChek® XS mPOC Kit—a mobile solution designed to work seamlessly with the CoaguChek XS meter to allow patient self-testers to wirelessly transmit PT/INR test results from their meter at home directly to CoaguChek Patient Services and their healthcare provider.

*Product is in development and not commercially available. ** 510(k) pending. Not available in U.S.

About Roche 
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-eight medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit or

All trademarks used or mentioned in this release are protected by law.

For further information, please contact:

Todd Siesky
Senior Director, Corporate Communications 
Roche Diagnostics Corporation
Indianapolis, Indiana USA
(317) 521-3966 or (317) 361-7637

SOURCE Roche Diagnostics
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas - Key Players are Roche, BMS, Sanofi, GSK, Boehringer Ingelheim, Celgene, Novartis and Pfizer
2. Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment
3. Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab
4. Guardant Health Appoints Mort Minaee, Former Roche Senior Director, as VP of Regulatory Affairs
5. Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche
6. Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating
7. System-wide standardization of laboratory testing with new Roche technology to offer patient, people and process benefits for BJC HealthCare
8. Rochester Drug Cooperative and Aureus Health Services Announce the Launch of a Specialty Pharmacy Management Program for Independent Retail Pharmacies
9. Global Cardiac Biomarkers Market 2014-2018: Key Vendors are Abbott Laboratories, Alere, Ortho Clinical Diagnostics and Roche Diagnostics
10. Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovios Hepatitis B Immunotherapy
11. Roche Teams Up with LabCentral to Support Biotech Startups
Post Your Comments:
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today ... Mandalay Bay Resort & Casino, Las Vegas on Oct. 15 – 19, 2019. ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... announced that FocalPoint Holdings, a privately-held investment and management firm specializing in ... than 8,000 ophthalmology and optometry providers Luma Health’s patient relationship technology to ...
(Date:10/8/2019)... ... ... ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, today announced ... and drive sales growth. , The following changes and new additions have been made ... to Senior Vice President of Strategic Partnerships; , Keith Clements hired ...
Breaking Medicine Technology:
(Date:10/8/2019)... ... 08, 2019 , ... What unique insights can three former Surgeons General of ... in the nation? That question will be answered at ICAA 2019: Shaping the Future ... The event will take place October 10-12, 2019, at the Gaylord Palms Resort and ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. Amir HagShenas of Silicon Valley Smile Solutions ... relief from this common and treatable condition. Dr. HagShenas’ goal is to treat ... with uncomfortable symptoms, including tender and bleeding gums, and to prevent gum disease from ...
(Date:10/8/2019)... ... 08, 2019 , ... As a world-renowned expert using intravital ... with the University of Maryland Department of Veterinary Medicine, continues to make new ... and his lab have discovered a new pathway by which liver macrophages called ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... and pathologists, 4medica® President Gregg Church will inform conference attendees how ... reinventing labs orders management-by starting with the right, clean patient data. The single ...
(Date:10/8/2019)... ... October 08, 2019 , ... The University of California ... Health Awards 1st Round (Top Ten) Finalist in its Best Cardiovascular Digital Diagnostic ... that promote faster, better, more cost-effective healthcare by improving outcomes such as shorter ...
Breaking Medicine News(10 mins):